Impacts of Drugs on Alzheimer’s Diseases

2021 ◽  
Vol 7 (3) ◽  
Author(s):  
Bharti R ◽  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Review Article ◽  
Older Person ◽  
Disease Treatment ◽  
Mental Functions ◽  
Treatment Techniques ◽  
Alois Alzheimer ◽  
Alzheimer’S Diseases ◽  
Alzheimer's Diseases

In 1901, Alois Alzheimer first reported Alzheimer’s disease. It is a disease that destroys memory and other essential mental functions mostly observed in an older person and mainly in women. Various treatment techniques have been used, which involve Ayurveda, homeopathy, modern drugs, etc. Turmeric, Ashwagandha, Brahmi, Ghrita, etc. are some ayurvedic medicines used to cure this disease, but they were relatively slow in processing. Drugs like Donepezil, Galantamine, and Rivastigmine are speedy, and thus they are in the market nowadays. In this review article, we will give information and awareness about the drugs therapy used for disease treatment and their effects.

scholarly journals A Global Review on Alzheimer’s Disease

2021 ◽  
Vol 68 (1) ◽  
Author(s):  
Natarajan. P ◽  
Mumthaj. P ◽  
Vijay. J ◽  
Gokul. V
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Cholinesterase Inhibitors ◽  
Genetic Factors ◽  
Environmental Changes ◽  
Late Onset ◽  
Memory Loss ◽  
Review Article ◽  
Acetyl Cholinesterase ◽  
Alois Alzheimer

Alzheimer’s disease (AD) is an inevitable neurological disorder in which the death of brain cells causes memory loss and cognitive decline and ultimate dementia. It’s the foremost common cause of dementia in people of 65 years and older. It was first described by a neurologist Alois Alzheimer in 1906. This review article gives an account on the various symptoms from pre-dementia to severe Alzheimer’s dementia. The Alzheimer’s disease is caused by the pathogenesis by accumulation of toxic amyloid-? plaques (A?) and Hyper phosphorylated tau (p-tau). The greatest risk factors for late onset Alzheimer’s are age, genetics, family history and non-genetic factors (heart health, life style modifications, and environmental changes). The diagnosis of AD advances in genetics, the event of biomarkers of neuro degeneration and neuroimaging discovery utilizes the method to detect AD. The medication use to treat AD is acetyl cholinesterase inhibitors and N-methyl D aspartate antagonists and various drugs are under clinical trials.

Huprine Y – tryptophan heterodimers with potential implication to Alzheimer’s disease treatment

2021 ◽  
pp. 128100
Author(s):  
Eva Mezeiova ◽  
Martina Hrabinova ◽  
Vendula Hepnarova ◽  
Daniel Jun ◽  
Jana Janockova ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Disease Treatment ◽  
Potential Implication

Computational modelling of potent β-secretase (BACE1) inhibitors towards Alzheimer's disease treatment

2021 ◽  
Vol 270 ◽  
pp. 106536
Author(s):  
Samuel C. Ugbaja ◽  
Zainab K. Sanusi ◽  
Patrick Appiah-Kubi ◽  
Monsurat M. Lawal ◽  
Hezekiel M. Kumalo
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Computational Modelling ◽  
Disease Treatment

Therapeutic and pharmacokinetic characterizations of an anti-amyloidogenic bis-styrylbenzene derivative for Alzheimer’s disease treatment

2013 ◽  
Vol 23 (11) ◽  
pp. 3467-3469 ◽  
Author(s):  
Seong Rim Byeon ◽  
Hyunjin Vincent Kim ◽  
Mijin Jeon ◽  
Young Gil Ahn ◽  
Maeng Sup Kim ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Disease Treatment
Sign in / Sign up

Export Citation Format

Share Document